153 related articles for article (PubMed ID: 36357242)
41. Regulation of Autoimmunity by the Microbiome.
Zárate-Bladés CR; Horai R; Caspi RR
DNA Cell Biol; 2016 Sep; 35(9):455-8. PubMed ID: 27463238
[TBL] [Abstract][Full Text] [Related]
42. Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.
Prado C; Osorio-Barrios F; Falcón P; Espinoza A; Saez JJ; Yuseff MI; Pacheco R
J Neuroinflammation; 2021 Dec; 18(1):292. PubMed ID: 34920747
[TBL] [Abstract][Full Text] [Related]
43. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry.
Ryan KR; Patel SD; Stephens LA; Anderton SM
J Autoimmun; 2007 Dec; 29(4):262-71. PubMed ID: 17870412
[TBL] [Abstract][Full Text] [Related]
44. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin.
Anderton SM; Wraith DC
Eur J Immunol; 1998 Apr; 28(4):1251-61. PubMed ID: 9565365
[TBL] [Abstract][Full Text] [Related]
45. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
[TBL] [Abstract][Full Text] [Related]
46. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not.
Dang AK; Jain RW; Craig HC; Kerfoot SM
J Neuroimmunol; 2015 Jan; 278():73-84. PubMed ID: 25595255
[TBL] [Abstract][Full Text] [Related]
47. Molecular mimicry as a mechanism of autoimmune disease.
Cusick MF; Libbey JE; Fujinami RS
Clin Rev Allergy Immunol; 2012 Feb; 42(1):102-11. PubMed ID: 22095454
[TBL] [Abstract][Full Text] [Related]
48. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
Wildner G; Diedrichs-Möhring M
Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
[TBL] [Abstract][Full Text] [Related]
49. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
Becher B; Bechmann I; Greter M
J Mol Med (Berl); 2006 Jul; 84(7):532-43. PubMed ID: 16773356
[TBL] [Abstract][Full Text] [Related]
50. Autoimmune ovarian disease: mechanism of disease induction and prevention.
Tung KS; Lou YH; Garza KM; Teuscher C
Curr Opin Immunol; 1997 Dec; 9(6):839-45. PubMed ID: 9492987
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
[TBL] [Abstract][Full Text] [Related]
52. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
Martinez-Pasamar S; Abad E; Moreno B; Velez de Mendizabal N; Martinez-Forero I; Garcia-Ojalvo J; Villoslada P
BMC Syst Biol; 2013 Apr; 7():34. PubMed ID: 23618467
[TBL] [Abstract][Full Text] [Related]
53. Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.
Weissert R; Svenningsson A; Lobell A; de Graaf KL; Andersson R; Olsson T
J Immunol; 1998 Jan; 160(2):681-90. PubMed ID: 9551903
[TBL] [Abstract][Full Text] [Related]
54. Molecular mimicry: can epitope mimicry induce autoimmune disease?
Davies JM
Immunol Cell Biol; 1997 Apr; 75(2):113-26. PubMed ID: 9107563
[TBL] [Abstract][Full Text] [Related]
55. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
56. Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity.
Chalmin F; Rochemont V; Lippens C; Clottu A; Sailer AW; Merkler D; Hugues S; Pot C
J Autoimmun; 2015 Jan; 56():45-55. PubMed ID: 25456971
[TBL] [Abstract][Full Text] [Related]
57. Infection-induced apoptosis deletes bystander CD4+ T cells: a mechanism for suppression of autoimmunity during BCG infection.
O'Connor RA; Wittmer S; Dalton DK
J Autoimmun; 2005 Mar; 24(2):93-100. PubMed ID: 15829401
[TBL] [Abstract][Full Text] [Related]
58. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis.
Gholamzad M; Ebtekar M; Shafiee Ardestani M
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):271-281. PubMed ID: 28732440
[TBL] [Abstract][Full Text] [Related]
59. [A view for understanding the pathogenesis of multiple sclerosis].
Tabira T
Rinsho Shinkeigaku; 1995 Dec; 35(12):1493-5. PubMed ID: 8752441
[TBL] [Abstract][Full Text] [Related]
60. Cyclosporine-induced autoimmunity and immune hyperreactivity.
Prud'homme GJ; Parfrey NA; Vanier LE
Autoimmunity; 1991; 9(4):345-56. PubMed ID: 1954315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
